Skip to main content
Caplight Logo









Acclaro Medical

Acclaro Medical

Private
Smithfield, Rhode IslandHealthcare & Life Scienceshttps://ultraclearlaser.com/

Last Round

Series B

May 29, 2025

Total Funding Raised

$23M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Acclaro Medical is a medical technology company that develops and markets energy-based medical solutions, including the UltraClear and AuraLux fiber laser systems for aesthetic and surgical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical laserskin resurfacingfiber laseraesthetic laserlaser skin rejuvenationdermatology lasercold lasermedical device manufactureraesthetic medicinelaser facialmed spa equipmentablative lasernon-ablative laserskin tighteninglaser scar treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Acclaro Medical Comparables

Compare Acclaro Medical with similar companies based on industry and business-model similarity.

Acclaro Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AVAVA
87%
Sciton, Inc.
85%
Aerolase
84%

Acclaro Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 29, 2025

Key People

Founding team and executive leadership

Helen F.

Chief Executive Officer

Executive Team

Ally Jin

Chief Financial Officer

Executive Team

Acclaro Medical Investors

Notable investors and investment history

Acclaro Medical investors
InvestorRounds
Bencao CapitalSeries B
AccelmedSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Grew 22% QoQ, from 104 to 127 employees.

  • Jul 13, 2026

    Open roles increased to 44, 36% of headcount.

Acclaro Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Acclaro Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Acclaro Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSmithfield, Rhode Island
Employee Range127
Year Founded2018
Last FundingMay 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?